Skip to main content

and
  1. No Access

    Article

    The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

    The aim of this study was the evaluation of the effect of intermediate doses of thalidomide with dexamethasone (Thal/Dex) on disease course and bone disease in patients with refractory/relapsed myeloma who wer...

    E Terpos, D Mihou, R Szydlo, K Tsimirika, C Karkantaris, M Politou in Leukemia (2005)